BeOne Medicines (BEIGF) EPS (Diluted) Growth (5y) (2021 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) EPS (Diluted) Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.62 Bn | 625.86 Bn | 17.26 Bn |
| 2 | AbbVie | 442.20 Bn | 435.63 Bn | 12.70 Bn |
| 3 | Merck | 366.42 Bn | 359.28 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.80 Bn | 259.11 Bn | 11.24 Bn |
| 5 | Pfizer | 159.12 Bn | 147.42 Bn | 10.94 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.39 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.45 Bn | 18.78 Bn | 683.80 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.05% |
| Mar 31, 2026 | 23.36% |
| Dec 31, 2025 | 15.97% |
| Sep 30, 2025 | 17.35% |
| Jun 30, 2025 | 17.01% |
| Mar 31, 2025 | 14.90% |
| Dec 31, 2024 | 25.90% |
| Sep 30, 2024 | 26.72% |
| Jun 30, 2024 | 5.31% |
| Mar 31, 2024 | 4.00% |
| Dec 31, 2023 | 5.56% |
| Sep 30, 2023 | 22.81% |
| Jun 30, 2023 | -1.41% |
| Mar 31, 2023 | -8.12% |
| Dec 31, 2022 | -14.98% |
| Sep 30, 2022 | -32.75% |
| Jun 30, 2022 | -24.52% |
| Mar 31, 2022 | -22.54% |
| Dec 31, 2021 | -41.02% |
| Sep 30, 2021 | -34.38% |